Glyconics

Cambridge, United States

Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

$2.0M raised

Nov 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Glyconics raised?

Glyconics has raised $2.0M in total funding. The most recent round was Series A. The last funding was announced in November 2021.

Who are Glyconics's investors?

Glyconics's investors include Innovate UK, Deepbridge Capital, Boundary Capital Partners LLP, Wealth Club, SBRI Healthcare.

Where is Glyconics headquartered?

Glyconics is headquartered in Cambridge, United States.

What does Glyconics do?

Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

What stage is Glyconics at?

Glyconics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 18, 2021.

MLA

"Glyconics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/glyconics. Accessed July 3, 2026.

APA

VCBacked. (2021). Glyconics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/glyconics

Wikipedia (cite web)

{{cite web |title=Glyconics — Funding & Investors |url=https://www.vcbacked.co/company/glyconics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 18, 2021.